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Hair cortisol concentration (HCC) is a promising measure of long-term hypothalamus-pituitary-adrenal 
(HPA) axis activity. Previous research has suggested an association between HCC and psychological 
variables, and initial studies of inter-individual variance in HCC have implicated genetic factors. 
However, whether HCC and psychological variables share genetic risk factors remains unclear. The 
aims of the present twin study were to: (i) assess the heritability of HCC; (ii) estimate the phenotypic 
and genetic correlation between HPA axis activity and the psychological variables perceived stress, 
depressive symptoms, and neuroticism; using formal genetic twin models and molecular genetic 
methods, i.e. polygenic risk scores (PRS). HCC was measured in 671 adolescents and young adults. 
These included 115 monozygotic and 183 dizygotic twin-pairs. For 432 subjects PRS scores for plasma 
cortisol, major depression, and neuroticism were calculated using data from large genome wide 
association studies. The twin model revealed a heritability for HCC of 72%. No significant phenotypic or 
genetic correlation was found between HCC and the three psychological variables of interest. PRS did 
not explain variance in HCC. The present data suggest that HCC is highly heritable. However, the data 
do not support a strong biological link between HCC and any of the investigated psychological variables.
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Research has generated robust evidence that chronic stress is a risk factor for mental disorders1,2. Understanding 
the mechanisms through which stress impacts mental health is therefore an important aim of epidemiological 
research. A core element of the biological stress response is the hypothalamus-pituitary-adrenal (HPA) axis. HPA 
axis activity is typically measured according to its end product, the steroid hormone cortisol. While prompt 
HPA axis activation in response to acute stressors is adaptive, long-term dysregulation of basal HPA axis activity 
and reactivity can have deleterious effects on physiology2,3. Alterations in HPA axis regulation are observed in 
subjects suffering from psychiatric disorders, and have been suggested as not only a consequence but also as a 
premorbid vulnerability factor4,5. Research has shown that variation in HPA axis regulation is influenced by both 
environmental and genetic factors6. Furthermore, authors have suggested that the effects of genetic and environ-
mental risk factors for psychiatric disorders might be mediated in part via dysregulation of HPA axis activity2,7. 
Investigating if HPA axis regulation shares underlying genetic factors with psychological or psychiatric pheno-
types can inform about a true biological link between these, potentially indicating a causal involvement of the 
HPA axis in the vulnerability for psychiatric disorders.
Cortisol is usually measured in saliva, urine, or blood8. However, single cortisol measures are strongly influ-
enced by factors such as circadian rhythm, physical activity, and nutrition. Thus the assessment of long-term 
alterations in HPA axis regulation requires the meticulous assessment of cortisol at multiple time points. In recent 
years, the assessment of hair cortisol concentration (HCC) has been established as a marker of long-term cumula-
tive HPA axis activity9,10. HCC is usually measured in a 3 centimeter (cm) hair segment cut as close as possible to 
the scalp. Since hair grows, on average, one cm per month, HCC in a 3 cm sample is considered to reflect cortisol 
secretion during the preceding 3 month period11. Hair cortisol is assumed to reflect free cortisol, which is the bio-
logically active share of cortisol not bound to corticosteroid binding globulin (CBG)12,13. Studies investigating the 
relationship of HCC with cortisol levels in other tissues show the highest correlations (up to r = 0.61) with cumu-
lative or average cortisol measures acquired over several days or weeks14–17. While these studies which assessed 
multiple measurement-points have been mainly carried out using saliva and urine, studies which used serum and 
plasma blood samples, have been mainly based on single assessments, and the observed correlations were lower 
or non-significant (e.g. refs18–20). Studies in pregnant women14,21 and in subjects with Cushing’s syndrome20,22 
-conditions characterized by pronounced alterations in circulating cortisol- have revealed altered HCC levels, and 
therefore indicate that HCC is a marker of long-term changes in circulating cortisol. HCC therefore represents 
an efficient method for the retrospective assessment of long-term cortisol secretion, and thus long-term HPA axis 
activity.
While HCC would thus appear to be an ideal biomarker for stress-related phenotypes, to date, studies of 
the association between HCC and measures of stress and mental health have generated inconsistent results (for 
review see refs9,10,23). A recent meta-analysis based on aggregated data from a total of 124 samples, and compris-
ing 10,289 subjects, showed no consistent associations with mood disorders or self-reported perceived stress and 
depressiveness, but found that stress-exposed groups as a whole exhibit 22% increased HCC24. While stressful 
environmental factors play a major role in HPA axis activation, twin studies have indicated that genetic factors 
have a substantial impact on the secretion of cortisol, especially morning cortisol. Predominantly moderate her-
itability estimates have been reported in adults (as reviewed in refs25–27) and adolescents25,27,28. The observed her-
itability of HPA axis regulation suggests a contribution of genetically determined biological mechanisms. To date, 
the only large genome wide association study (GWAS) systematically investigating the genes underlying HPA axis 
activity used total plasma cortisol levels in the morning: Bolton et al. (2014) identified associated genetic variants 
in a region which contains the genes encoding CBG and α1-antitrypsin29. If a strong heritability for HCC could 
been confirmed, HCC would represent a promising target for genetic studies into long-term HPA axis activity 
and its relationship to mental health.
The first study on heritability of HCC was conducted in a colony of female vervet monkeys, and heritability 
estimates of ~30% in high and low stress environments were reported30. In humans, Tucker-Drob et al. (2017) 
demonstrated heritability of HCC for the first time by investigating an ethnically and socioeconomically diverse 
sample of 1070 children and adolescents including 533 twin pairs31. The authors showed that 65% of the total 
variability of HCC was explained by additive genetic effects, and that genetic influences on HCC decreased with 
age. In subjects with low socioeconomic status, a non-significant trend was observed towards increased genetic 
influences and reduced shared environmental influences on HCC. The authors hypothesized that genetic influ-
ences may be stronger under high stress conditions.
As mentioned above, a genetic overlap between HPA axis activity and psychological or psychiatric phenotypes 
would suggest an involvement of the HPA axis in the vulnerability to psychiatric disorder. However, previous 
studies investigating a possible genetic overlap between cortisol secretion and psychological variables have been 
limited in both number and size: A study in 29 monozygotic female twin pairs suggested around 40–45% of 
the total variance in morning and evening saliva cortisol levels is shared by monozygotic twins32. Furthermore, 
increased (p = 0.06) mean cortisol levels were observed in those twins with a history of major depression (MDD). 
Notably, intermediate cortisol levels were observed in twins without history of MDD from pairs discordant for 
history of MDD, however these observations were not significant. A study conducted in 125 female twin pairs 
demonstrated a heritability of 55% for neuroticism and a heritability of up to 69% for morning cortisol secre-
tion in saliva33. However, the authors found no phenotypic or genotypic association between cortisol levels and 
neuroticism.
Rietschel and Fabian Streit contributed equally to this work. Nicholas G. Martin and Marcella Rietschel jointly 
supervised this work. *A comprehensive list of consortium members appears at the end of the paper. Correspondence 
and requests for materials should be addressed to L.R. (email: Liz.Rietschel@srh.de)
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In a previous twin study, the present authors demonstrated that continuous measures of perceived stress, 
depressive symptoms, and neuroticism were heritable and showed strong phenotypic and genetic correlations 
in healthy adolescent and young adult twins34. In line with this, recent large genome-wide studies have demon-
strated that genetic variants make a substantial contribution to the development of neuroticism35,36, depressive 
symptoms36, and MDD37. These studies have also revealed that these risk variants show partial overlap. In a sub-
sequent pilot study, the present authors measured HCC and the three psychological variables in a sample of 109 
children and young adults, which included eight monozygotic- and 21 dizygotic twin pairs38. Due to the small 
sample size, no reliable heritability estimates for HCC could be generated. However, the findings suggested that 
HCC and the assessed psychological variables may share a common genetic basis.
The present larger study aimed (i) to estimate the heritability of HCC and (ii) to investigate the question of 
whether HPA axis activity shows a genetic overlap with the continuous psychological measures perceived stress, 
depressive symptoms, and neuroticism, using formal genetic (twin models), and molecular genetic methods i.e. 
polygenic risk score (PRS) analyses. PRS provide a quantitative measure of genetic risk or vulnerability for a given 
trait. PRS estimation uses GWAS results to predict genetic risk for each individual in an independent genotyped 
sample. Investigations can then be performed to determine whether this risk is associated with potentially related 
phenotypes. However, while significant associations can be found using this approach, the explained variance 
is limited. For the purposes of the present study, PRS were calculated based on results from GWAS of HPA axis 
activity29; MDD37; and neuroticism35. Since the GWAS of HPA axis activity was based on plasma cortisol levels, 
the association between HCC and this PRS was explored i.e. the association between HCC and the genetic vari-
ants influencing concentration of cortisol in another tissue.
Materials and Methods
Subjects. Our samples consisted of adolescent and young adult twins from the Brisbane area recruited mainly 
for studies of the genetics of melanoma risk factors and cognition; we neither selected nor excluded participants 
for any particular phenotype, nor did we systematically obtain data on medical history and treatment. Hair sam-
ples were collected from 674 adolescents/young adults. After exclusion of four hair samples (see ‘hair sampling 
and HCC analysis’), the final cohort comprised 671 subjects (age mean = 14.5±2.4 years; range = 10.1–31.1 years; 
419 females). The cohort included 116 monozygotic (MZ) and 187 dizygotic (DZ) twin pairs (3 families had two 
sets of DZ twins), and 14 sets of trizygotic triplets. For the purposes of the present analyses, each set of triplets 
was considered to be a DZ twin pair with one additional singleton. The cohort included a total of 65 singletons, 
who were derived from the divided triplets (n = 14) and the siblings of the MZ and DZ twin pairs (n = 51) (for 
details see Supp. Table 1).
All subjects had participated in at least one phase of the Brisbane Longitudinal Twin Study39,40. This ongoing, 
longitudinal study of adolescent/young adult twins and siblings from the general population of the Brisbane area 
(Australia), is conducted in several phases and investigates somatic- and mental health and related phenotypes 
(for details see Supp. Text and Supp. Table 2). For 146 subjects (including 29 MZ and 42 DZ twin pairs), hair sam-
ples were collected at two time-points (73 subjects at 12 and 14 years; 73 subjects at 14 and 16 years; for details see 
Supp. Table 1b). Stability of HCC and the psychological variables was assessed in terms of correlations between 
the two time points (for details see Supp. Table 1b). For 432 subjects (age mean =  15.5± 2.4 years; range =  10–31 
years; 268 females), genome-wide genotype data were available (for details see Supp. Table 1c). The study was 
approved by the Human Research Ethics Committee of the Queensland Institute of Medical Research (QIMR) 
and conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from all 
subjects, and from legal guardians in the case of minors, prior to inclusion and sample collection.
Psychological variables. For participants less than 16 years old, perceived stress was measured using the 
30-item ‘Daily Life and Stressors Scale’ (DLSS41) and neuroticism was measured using the respective 20 items of 
the ‘Junior Eysenck Personality Questionnaire’ (JEPQ42) as the DLSS and JEPQ are validated for children and 
adolescents. For participants aged 16 years or older, perceived stress was measured using the 10-item ‘Perceived 
Stress Scale’ (PSS44). Additionally, 168 subjects between 16 and 19 years completed both the PSS and the DLSS, 
and this overlap was used to harmonize the two scales using item response theory (IRT; see below). For partic-
ipants aged 16 years or older, neuroticism was measured using the respective 12 items of the ‘NEO-Five Factor 
Inventory revised version’ (NEO-FFI-R44). At all ages, depressive symptoms were assessed using the 34-item 
‘Somatic and Psychological Health Report’ (SPHERE;45). For all subjects, measures of stress (PSS or DLSS), neu-
roticism, and depressive symptoms were obtained at the time of hair sampling. For some subjects, data were 
unavailable for perceived stress (n = 1); neuroticism (n = 51); and depressive symptoms (n = 55), since subjects 
did not fill out the respective questionnaires. In the subgroup that underwent assessment at two time-points, one 
subject had missing data for perceived stress and depressive symptoms at the second time point.
Hair sampling and HCC analysis. Using fine scissors, a 3 cm hair swatch of approximately 3 millimeters in 
diameter was cut as close as possible to the skin from the posterior vertex of the scalp. Hair cortisol was analyzed 
by TMB and MRB at the Institute of Forensic Medicine, Centre for Forensic Hair Analysis, University of Zurich. 
Cortisol concentration was measured using liquid chromatography-tandem mass spectrometry (LC-MS/MS), as 
described by Binz et al.46 (for details see Supp. Text). Prior to HCC measurement, hair samples were randomly 
assigned to batches (irrespective of time-point or twin-pair) in order to minimize the effect of batch differences 
on twin correlations. To assess technical error, 106 hair samples were assessed in duplicate and 27 in triplicate. 
The hair samples were assayed between April and July 2016 in a total of 35 batches (comprising 27 samples 
respectively). Samples with extreme high or low values (n = 26; 13 ≤ 0.2 and 13 ≥ 26.3) were re-assayed in order 
to confirm the extreme values.
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Statistical Analysis. Treatment of psychological variables and HCC. To harmonize neuroticism scores, 
the neuroticism sum-scores of the NEO-FFI-R and the JEPQ scores were separately z-transformed and then 
combined, as described in previous studies47,48. To harmonize data from the two stress rating scales DLSS and 
PSS, Item Response Theory (IRT) analysis was performed (for raw values and details see Supp. Text and Supp. 
Table 3). IRT models have the advantage that the difficulty and discriminability of each item is taken into account 
by modeling a normally distributed liability based on the responses to the individual questionnaire items. It is 
thus superior to a simple sum score that assumes all items have the same discriminating ability with respect to the 
underlying liability being measured and is thus particularly useful if widely different scales are being combined–
as here for perceived stress. We made use of the overlapping cases who had completed both scales in order to put 
both measures on the same liability scale. IRT analysis was also applied to the 34 items from the SPHERE in order 
to produce a single liability measure for depressive symptoms.
To account for skewness, raw HCC values (mean = 6.29 pg/mg; SD = 28.92; range = 0–560) were log trans-
formed. Here, the lowest measured value (0.1) was added to each value prior to log10 transformation. Five out-
liers>3SD (HCC>64.70 pg/mg) were winsorized to 3SD on the lg10 scale. Analyses were also conducted to test 
the effect of experimental variables reported in previous studies of HCC. The analyses included: (i) batch number 
(n = 35); (ii) study phase (n = 6); (iii) storage time, defined as time between date of collection and date of assay 
(range = 0.50–4.02 years) and divided into n = 5 groups according to increasing storage time; and (iv) sun expo-
sure, operationalized according to month of assessment (n = 12) and self- and maternal ratings of sun exposure. 
Since all aforementioned variables changed the fit of the model significantly, they were regressed out from the 
HCC measurement using a linear model, including the dummy coded variables as fixed effects. Subsequent anal-
yses were carried out with the residuals of this model. The HCC value from the first time point was used in the 
following analyses; the second time point was only used for assessing stability of HCC over a two-year period in 
the subset of longitudinally assessed subjects (n = 146).
Twin correlations, heritability of HCC, and shared covariance with psychological variables. To estimate twin cor-
relations and the heritability of HCC and the three psychological variables of interest, the twin and sibling data 
were used to generate structural equation models. Model parameters were estimated using the full maximum 
likelihood method implemented in Mx49. This makes use of all data points - including those of unpaired twins 
and singletons - in order to improve estimation of sample means and variances. This approach allows partitioning 
of the variation into: additive genetic influences (A); shared environmental influences (C); and unique environ-
mental influences (E). Using likelihood ratio chi-square tests, sub-models with only two factors (AE and CE mod-
els) were compared with the three-factor models (ACE) in order to estimate the sources of variance and select the 
most parsimonious variance structure of the traits.
To investigate the influence of genetic and environmental factors on HCC and the psychological variables 
of interest, as well as genetic and environmental correlations between these variables, multivariate analysis was 
performed. This involved use of a simultaneous Cholesky decomposition. A Cholesky decomposition is a good 
initial multivariate method to use in the absence of a clear model of the factor structure relating a set of correlated 
variables. Furthermore, taking advantage of having both MZ and DZ twins one can fit a 3-part Cholesky model 
including decompositions of (co)variance due to A (additive genetics), C (shared environment) and E (unique 
environment), since one cannot assume that factor loadings between these three sources of variation will be 
proportional for each of the examined variables. In fact, there are known cases of opposite-signed loadings of 
factors A and C (e.g., for items of Eysenck’s Psychoticism scale50). The source of variation, C, captures cultural 
environment shared by twins within a family regardless of zygosity and could include factors such as sharing the 
same school, neighborhood, and exposure to infectious diseases. C is distinguished from unique environment, E, 
which is specific to individuals and may include factors such as accidents; however, it is important note that E also 
includes measurement error, which is often the major contributor to this source of variance. An ACE Cholesky 
decomposition model was compared with an AE and a CE Cholesky decomposition. Perceived stress was used as 
the first, depressive symptoms as the second, neuroticism as the third, and HCC as the last latent factor in order 
to estimate (i) the genetic variance of HCC that is shared with genes affecting the psychological variables and (ii) 
the independent genetic variance for HCC after removing the effects of the genes with the primary influence on 
the psychological variables (for further details see Supp. Text).
The fit of each model was assessed according to the differences in log likelihood between the sub and the 
full models. The most parsimonious model was chosen for the purposes of data interpretation. Sex and puberty 
which - generally starts earlier in girls- influence the cortisol secretion51. As puberty status was not assessed in 
the study, sex, age, age², sex x age, and sex x age² were included as covariates in all models, to allow for different 
age effects in boys and girls and the fact that these may be curvilinear. Body mass index (r = 0.06, p = 0.11), 
socio-economic index (r = -0.07, p = 0.13), and hair dyeing (r = 0.01, p = 0.81) showed no significant associations 
with HCC in the present sample and were thus not included as covariates. Since previous results suggest that 
heritability of HCC is age-dependent31, a separate analysis was performed in the younger and the older half of the 
sample, as defined by a median split to test the heritability of HCC in the different age groups. Further details of 
the twin design and analytical methods, including assumption testing and multivariate modeling, are provided 
elsewhere52.
Genotyping, quality control, and imputation. Genotyping was performed using the Illumina Human610-Quad 
and Core+Exome SNP chips. Quality control included inspection of pedigree, sex, Mendelian errors, and 
ancestry, as well as filtering for genotyping quality (GenCall <0.7); SNP and individual call rates (<0.95); 
Hardy-Weinberg equilibrium failure (P <10–6); and minor allele frequency (<0.01). Subjects were imputed to 
the Haplotype Reference Consortium (HRC.1.1)53 on the Michigan Imputation Server (https://imputationserver.
sph.umich.edu/i). Imputation was carried out in two separate waves for the Illumina Human610-Quad and the 
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Core+Exome SNP chips. To account for population stratification (i.e. allele frequency differences between sub-
jects due to systematic ancestry differences) in the PRS analysis, genetic principal components (PC) reflecting the 
respective ancestry were calculated using EigenSoft 6.0.1 (http://www.hsph.harvard.edu/alkes-price/software/). 
Further details on genotyping, quality control, and imputation are provided in the Supp. Text.
Polygenic risk score analysis. PLINK 1.90 (version 3, May 2016, https://www.cog-genomics.org/plink2/) was 
used to compute PRS in accordance with the procedure described by Wray et al.53. For PRS estimation, the results 
of large GWAS (discovery sample) are used to calculate an aggregated genetic risk score for each individual in 
an independent genotyped sample (target sample). The PRS represents the sum of the risk alleles, as weighted by 
their respective estimated effect sizes. PRS provide a quantitative measure of the genetic risk or vulnerability for a 
given trait: The higher the score, the higher the predisposed genetic risk of the individual for the trait in question. 
In the present study, PRS were calculated using summary statistics from recent GWAS or GWAS meta-analyses 
of: (i) plasma cortisol (CORtisol NETwork (CORNET) Consortium29, comprising 12,597 subjects); (ii) MDD 
(PGC-MDD237 minus QIMR samples, comprising a total of 49,524 cases and 110,074 controls, for details see 
Supp. Table 4); and (iii) neuroticism (UK Biobank35, comprising 91,370 subjects). The SNP-sets used to compute 
the PRS were selected using eight different p-value thresholds (5e-8, 1e-5, 0.001, 0.01, 0.05, 0.1, 0.5, 1.0) in the 
respective discovery sample.
To take family structure into account, associations of PRS with HCC and the three psychological variables 
of interest were tested using linear mixed regression models in GCTA (Genome-wide Complex Trait Analysis v. 
1.26)55. Here, the following were used as covariates: sex; age; age²; sex x age; sex x age²; the first five genetic prin-
cipal components (PC); and the imputation wave. One-sided p-values are reported, according to the hypothesis 
of a positive association of the PRS with HCC and each of the psychological variables. Further details of the PRS 
analysis are provided in the Supp. Text.
Data availability. The datasets generated during and/or analyzed during the current study are not publicly avail-
able due to privacy regulations but are available from the authors on reasonable request.
Results
Clinical characteristics of the cohort. HCC was measured in 671 subjects. HCC, neuroticism and depres-
sive symptom scores were higher in females than in males. Furthermore, perceived stress, depressive symptoms 
and neuroticism showed an association with age, and perceived stress and neuroticism showed an interaction of 
sex and age. Details can be found in Supp. Table 5. Distributions for age and all variables are shown in Table 1.
Influence of experimental covariates on HCC. Quality control of HCC assessed in duplicate and tripli-
cate revealed a high correlation of the log transformed HCC values for samples re-assayed once (n = 106; r = 0.89) 
and samples assayed three times (n = 27; r = 0.98 with the 1st and r = 0.98 with the 2nd assay).
Analysis of the influence of experimental covariates resulted in a final model with a total of 54 deviations for 
experimental effects (34 for batch number, 4 for storage time, 11 for month, and 5 for the respective study phase). 
All of these experimental covariates were highly significant. Notably, the analysis demonstrated: (i) a decrease in 
HCC with increasing storage time; and (ii) maximum values in March (end of the Australian summer) and mini-
mum values in September (end of the Australian winter). Dropping any one of the covariates from the full model 
(which includes all four) increased variance by 5.9% for batch effects, 1.8% for storage effects, 3.8% for month 
effects, and 6,4% for study effects (details see Supp. Table 6).
Heritability. For HCC, a DZ correlation of r = 0.42, and a MZ correlation of r = 0.66 were observed. This 
corresponded to a heritability estimate of h² = 0.72 in the multivariate model including HCC and the psycholog-
ical variables. Slightly lower DZ and MZ twin correlations were observed for the psychological variables. Here, 
the heritability estimates were h² = 0.54 for perceived stress; h² = 0.55 for depressive symptoms; and h² = 0.56 for 
neuroticism (see Table 2).
Stability over time. As shown in Table 2, stability over the two-year period ranged between r = 0.51 and 
r = 0.61 for the psychological variables, while HCC stability was r = 0.32.
Correlation of HCC with psychological variables. High phenotypic correlations were found between 
the three psychological measures, ranging from r = 0.59 to r = 0.64 (Supp. Table 7). In contrast, negligible 
Total (n = 671) Male (n = 252) Female (n = 419)
Age (years) 14.49 (2.43) 14.42 (2.59) 14.53 (2.32)
Perceived stressa 0.01 (0.58) −0.02 (0.61) 0.03 (0.57)
Depressive symptomsb 0.01 (0.92) −0.09 (0.94) 0.07 (0.90)
Neuroticismc 0.01 (1.01) −0.12 (1.02) 0.08 (0.99)
Hair cortisol (pg/mg) 5.31 (14.23) 5.68 (18.42) 5.09 (10.98)
Table 1. Means (SD) for age, psychological variables and HCC. Abbreviations: SD = standard deviation. aIRT-
scores deriving from perceived stress questionnaires (DLS and PSS); bIRT-scores of the SPHERE cz-standardized 
values of the neuroticism questionnaires.
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correlations were observed between the three psychological measures and HCC, with r = 0.04 for perceived stress; 
r = 0.07 for depressive symptoms; and r = 0.08 for neuroticism. None of these correlations differed significantly 
from zero.
As counterbalancing genetic and environmental correlations of opposite sign resulting in a small or zero phe-
notypic correlation have been observed for psychological measures (e.g. psychoticism)49, these associations were 
further explored with a multivariate Cholesky decomposition (Fig. 1). The C matrix, which accounts for shared 
environmental influences, could be dropped from the model without worsening fit (Δc2 = 13.66, p = 0.19). The 
AE model revealed low and non-significant genetic correlations (rA) between HCC and the three psychological 
variables (rA = 0.14 for perceived stress; rA = 0.12 for depressive symptoms; rA = 0.19 for neuroticism) (Table 3).
Separate AE Cholesky analysis was then performed for the younger (mean age = 12.37 (SD = 0.54) (Supp. 
Table 8), and the older (mean age = 15.70 (SD = 2.32)) (Supp. Table 9) halves of the cohort (divided by median; 
Mdn = 14.01 years). Comparable heritability estimates for HCC were found in the younger (h2 = 0.74) and older 
(h2 = 0.69) halves of the cohort. Heritabilities for the psychological variables were also broadly consistent between 
the younger and older halves of the sample (see Supp. Tables 8 and 9).
Association of polygenic risk for plasma cortisol, MDD, and neuroticism with HCC and psycho-
logical variables. The PRS for plasma cortisol showed no significant association with the HCC at any of the 
chosen thresholds (Fig. 2D). Furthermore, the PRS for plasma cortisol did not predict any of the three psycholog-
ical variables (Fig. 2A–C). The PRS for MDD and the PRS for neuroticism showed positive associations with the 
psychological variables. For several p-value thresholds, in particular thresholds>0.01, these associations reached 
nominal significance (see Fig. 2A–C). No significant association was found between HCC and the PRS for MDD 
or the PRS for neuroticism (Fig. 2D). Details of the PRS regression analyses are provided in Supp. Tables 10–21.
Discussion
To our knowledge, the present study is the first to assess the heritability of HCC together with its phenotypic and 
genetic association with perceived stress, depressive symptoms, and neuroticism.
The analyses generated a heritability estimate for HCC of ~70%, with no significant contribution being found 
for shared environment. These estimates are nearly identical to those reported by Tucker-Drob and colleagues31 
rMZ (115 pairs) rDZ (183 pairs) Heritabilitya
Two year Stabilityb 
(n = 146)
Perceived stress 0.51 (0.37–0.61) 0.29 (0.17–0.40) 0.54 (0.42–0.64) 0.61 (0.50–0.69)
Depressive symptoms 0.55 (0.43–0.65) 0.27 (0.13–0.40) 0.55 (0.42–0.65) 0.51 (0.37–0.62)
Neuroticism 0.53 (0.42–0.62) 0.31 (0.17–0.44) 0.56 (0.45–0.67) 0.58 (0.46–0.67)
Hair cortisol 0.66 (0.56–0.74) 0.42 (0.31–0.51) 0.72 (0.63–0.79) 0.32 (0.16–0.45)
Table 2. Monozygotic (MZ) and dizygotic (DZ) twin correlations (95% CI), heritability and stability over two 
years, for the psychological variables and HCC. Abbreviations: CI = confidence interval, rDZ = correlation 
between dizygotic twins, rMZ = correlation between monozygotic twins. All calculations were corrected for sex, 
age, age2, sex x age, sex x age2. aHeritabilities were estimated using the multivariate model (see Fig. 1). bTwo year 
stability was calculated as the correlation between time point 1 and time point 2.
Figure 1. Cholesky Decomposition for the AE Model. Latent factor loadings are standardized to unit 
variance and must be squared to obtain standardized variance components. A1-A4 additive genetic factors, 
E1-E4 unique environmental factors. Abbreviations: STR = perceived Stress, DEP = depressive symptoms, 
NEU = neuroticism, HCC = hair cortisol concentration.
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and at the upper end of those reported for measures of cortisol in other tissues (e.g. saliva and urine). This is not 
surprising, given that HCC is an integrated, rather than a point measure of HPA axis activity. It can now be taken 
as a fact that in adolescents from the general population, a substantial proportion of HCC variance is attribut-
able to genetic factors. At first glance, this may appear surprising for a parameter that is considered a potential 
biomarker for stress. However, this finding does not preclude environmentally induced changes. Furthermore, 
the stability of HCC, as measured in a subgroup over a two-year period, is relatively low (r = 0.32). These sta-
bility measures are comparable to those found in students aged 17–21 years assessed at three time points over 
one year (r = 0.25–0.39)56 and to those found in children aged 1, 3, 5, and 8 years, in whom HCC was assessed 
over periods of two and three years (r = 0.30–0.44)57. In samples with a higher mean age (>30 years), in which 
intervals of assessment ranged between one month and one year, higher stability measures (r = 0.68−0.86) have 
been reported17,58. These findings are in line with the hypothesis of greater changes of HPA axis functioning dur-
ing childhood and adolescence which are periods marked by dramatic physical, cognitive, social and emotional 
changes56. Unfortunately, no conclusions can be drawn from the present analyses concerning the heritability of 
the intra-individual change in HCC over time, since the respective subsample was small and lacked sufficient 
statistical power for this analysis. However, it is of interest to note, that the heritability estimate of HCC did not 
differ between the younger and older half of the sample.
Regarding the phenotypic and genetic correlations of HCC with psychological variables, the present analyses 
demonstrated that shared genetic factors underlie the association between the psychological variables perceived 
stress, depressive symptoms, and neuroticism. The heritability of neuroticism and depression59–61, as well as their 
genetic overlap62,63, are well established, and the present data are consistent with those of previous reports.
(I) Standardized Parameters % (II) Correlations
1 2 3 4 1 2 3 4
Genetic (A)
1-Perceived stress 53.89 1
2-Depressive symptoms 32.95 22.10 0.77 1
3-Neuroticism 33.78 2.79 19.81 0.77 0.74 1
4-Hair cortisol 1.33 0.03 1.20 69.37 0.14 0.12 0.19 1
Unshared 
Environment 
(E)
1-Perceived stress 46.12 1
2-Depressive symptoms 6.65 38.30 0.35 1
3-Neuroticism 12.15 5.00 26.48 0.53 0.52 1
4-Hair cortisol 0.68 0.07 0.21 27.02 0.16 0.11 0.19 1
Table 3. Results of the Cholesky Decomposition for the AE Model, with (I) Standardized Parameters and (II) 
Genetic and environmental correlations between HCC and psychological measures.
Figure 2. Association of polygenic risk scores (PRS) for plasma cortisol, neuroticism, and major depression 
(MDD) with: (A) perceived stress; (B) depressive symptoms; (C) neuroticism; and (D) hair cortisol 
concentration. Negative R² indicates a negative direction of the association of PRS with the respective 
phenotype; p one-sided: **p < 0.01; *p < 0.05; #p < 0.1.
www.nature.com/scientificreports/
8Scientific RepoRts | 7: 15351  | DOI:10.1038/s41598-017-11852-3
However, contrary to the results of our previous pilot study38, no significant phenotypic or genetic overlap was 
found between HCC and any of the three psychological variables. Although no study to date has investigated the 
association between HCC and neuroticism, the present results are consistent with a previous investigation of 125 
twin pairs, which showed heritability for neuroticism and morning cortisol secretion in saliva but no phenotypic 
or genetic overlap between these two variables33.
The present findings must be viewed with caution, as they are derived from a cohort of relatively healthy ado-
lescents from the general population. It is possible that the association between HCC and psychological variables 
may only become apparent for more extreme psychological phenotypes. While studies of subjects with a history 
of chronic or traumatic psychological disturbance, i.e., conditions which are known to alter HPA axis functioning 
(e.g., shift work, earthquake, or civil war), have repeatedly reported HCC alterations64–66, previous reports on 
the association between HCC and psychological variables in healthy subjects are inconsistent (e.g. refs9,67–72). 
Recently, this was reflected in a meta-analytic study, which found no evidence for a positive association of HCC 
with subjective stress and depressivity24. However, the meta-analysis confirmed that HCC is increased in condi-
tions of chronic ongoing stress, and therefore represents a marker for the assessment of long-term alterations in 
cortisol levels in response to environmental influences24.
In the present sample, we observed values within the normal range of the applied psychological scales (see 
Supp. Table 3). If significant alterations in HCC only occur in response to major (and chronic) stressors, genetic 
and phenotypic correlations between HCC and psychological variables may only become observable in subjects 
who display more pronounced phenotypes, such as full-blown psychiatric disorders, or who are subjected to 
extreme levels of stress. Therefore, future genetic studies should investigate groups that are extreme in terms of 
perceived stress (e.g. after traumatic events), or twin pairs in which at least one twin has severe mental health 
problems.
Additionally, such studies should aim to further dissect the factors underlying HPA axis deregulation by 
including -besides basal measures such as HCC- dynamic measures of HPA axis (re-)activity, such as circadian 
rhythm, and reactivity to psychological, physical and pharmacological challenges, which are commonly assessed 
using multiple saliva or blood samples within a defined sampling scheme. Those measures have been shown to 
be altered in psychiatric disorders, partially independent of or even contrary to alterations in basal cortisol levels 
(e.g. as measured in saliva or blood)73,74. Another aspect future studies should address is the interplay of HCC 
with other hormones known to affect HPA axis activity, which can also be measured in hair, such as cortisone or 
gonadal steroids.
The molecular genetic approach i.e. using polygenic risk scores to investigate the association between HCC 
and psychological measures generated several interesting results. First, the observation of nominally significant 
positive associations of the PRS for MDD and the PRS for neuroticism with the psychological variables is con-
sistent with reported formal genetic correlations. This supports the validity of the approach, even in a sample as 
small as that used in the present analyses. However, the relatively low degree of explained variance, and the fact 
that the associations only achieved nominal significance at some of the selected thresholds, highlights that our 
approach lacks sufficient power. Second, the observation that neither the PRS for MDD nor the PRS for neuroti-
cism predicted HCC, and that the PRS for plasma cortisol did not predict perceived stress, depressive symptoms, 
or neuroticism, parallels the genetic results from twin models, which suggests a lack of genetic overlap between 
HCC and the psychological variables. Interestingly, no overlap was found between the PRS for plasma cortisol 
and HCC. For the interpretation of this result it is important to note, that hair cortisol is assumed to reflect free 
(unbound) cortisol, while the GWAS investigated total (bound and unbound) plasma cortisol concentrations12,13. 
The main signal of the GWAS was observed in the region coding for CBG, the main regulator of the ratio of free 
and total cortisol29 and might thus differentially affect measures of free and total cortisol. Additionally, HCC rep-
resents a measure of accumulated long-term cortisol secretion, while the GWAS was based on a one-time meas-
ure of morning plasma cortisol. As described, the correlations between HCC and one time measures of cortisol in 
saliva and blood are inconsistent. However, in view of the limited power, the results of the PRS analyses must be 
interpreted with caution, and large future studies of easier-to-recruit, unrelated subjects might generate insights 
into the associations. Additionally, even though each of the GWAS considered in the present analyses involved 
cohorts in excess of 10,000 subjects and identified genome-wide genetic variants, larger studies are required. 
Research has demonstrated that for complex phenotypes, GWAS involving several 100,000 subjects are needed 
to identify the majority of the common polygenic variation54,75. The power of PRS calculated using future GWAS 
will be increased due to a superior signal to noise ratio in these larger datasets.
Limitations
The present findings should be interpreted with caution, since the study had several limitations. First, the sample 
size was relatively small in terms of the establishment of twin models, particularly in the case of the exploratory 
analyses investigating subsamples divided by age, and the detection of small correlations between HCC measures 
and psychological phenotypes. Second, generalizability of the results to the general population is limited, since 
a young and relatively healthy cohort was investigated using self-rating questionnaires. Phenotypic and genetic 
correlations with psychological variables may only become evident in cohorts with more pronounced or specified 
environmental impacts (e.g. chronic severe stress) and more extreme phenotypes (e.g. psychiatric disorders, bio-
logically relevant endophenotypes). Under the challenge of more adverse environments, stronger variance might 
occur in those phenotypes, partially driven by distinct genetic factors. Third, we did control for age and sex and 
interactions in our analyses. However, there is evidence that the influence of puberty processes on the associa-
tions between HPA axis activity with stress and depressive symptoms is best accounted for by assessing pubertal 
status and timing (e.g. refs76–78). Future studies of HCC in adolescents should consider including those measures. 
Fourth, the self-rating questionnaires for perceived stress and depression do address shorter time frames (last 
week to last few weeks) than the time frame reflected in the 3 cm segments of hair analyzed for hair cortisol (~3 
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months). However, we observed a high heritability and stability (over two years) of the psychological measures in 
our sample. This indicates that these measures largely assess more stable components of the underlying psycho-
logical constructs and not merely short term fluctuations. Here, however, we must acknowledge the difficulty for 
researchers in this area of finding state effects convincingly independent of trait disposition. Fifth, the PRS scores 
for neuroticism, MDD, and plasma cortisol were derived from adult cohorts, and statistical power was small due 
to the limited size of the learning and present cohorts. Replication studies in much larger cohorts are required 
before further conclusions can be drawn, in particular as regards the genetic overlap between plasma cortisol 
and HCC. Sixth, although the present analyses demonstrate that HCC can be assessed with a high degree of reli-
ability, the quality control analysis demonstrated that various factors influenced HCC, including batch number, 
season, storage time, and study phase, and had to be statistically controlled for. Fifth, these corrections may have 
contributed to an overcorrection, and thus to the overlooking of true findings. Seventh, we did not systematically 
obtain data on medical history or treatment, including oral contraceptives. However, as the major part of our 
sample is less than 16 years of age, it is unlikely that oral contraceptives and other medications represent a major 
confounder. Furthermore, unlike cortisol assessed in other tissues6, there is no strong evidence that oral contra-
ceptives have a substantial effect on HCC (e.g. refs23,24,79). Eighth, hair dyeing did not affect HCC in the present 
sample. However, further variables such as frequency of hair washing were not assessed.
Conclusions
Our study demonstrates a high heritability of HCC, but no evidence for a genetic overlap with depressive symp-
toms, perceived stress and neuroticism. HCC is a reliable measure of long-term HPA axis activity and genetic 
effects play a major role in inter-individual variability. This knowledge will inform future research, and is of 
particular relevance in terms of the interpretation of data from cross-sectional studies. If a genetic or pheno-
typic correlation does exist between HCC and perceived stress, depressive symptoms, or neuroticism, the present 
analyses have demonstrated that this is difficult to identify in a relatively small sample of young adults from the 
general population. Further studies are warranted to investigate whether this is also the case in samples with 
more extreme psychological phenotypes. Particularly in studies for which blood or saliva sampling over several 
days and multiple time-points is difficult to implement, HCC represents a promising alternative measure for the 
assessment of long-term HPA axis activation. The high heritability, easy accessibility and cost-effectiveness of 
HCC render it a promising target for future large scale GWAS of the biological pathways that underlie long-term 
cortisol secretion and its links to stress-related phenotypes.
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